We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
  • Melinta Announces Termination of Merger Agreement for Tetraphase americanpharmaceuticalreview
    July 03, 2020
    Melinta Therapeutics announced pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp.
  • FDA Approves Tetraphase's XERAVA contractpharma
    August 29, 2018
  • Tetraphase enters into agreement with Biopharma firm in China biospectrumasia
    February 26, 2018
PharmaSources Customer Service